Travere Therapeutics, Inc. TVTX Preferred Stock
Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockValue.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Travere Therapeutics, Inc.'s preferred stock?
- Travere Therapeutics, Inc. (TVTX) reported preferred stock of $0 in Q1 2026.
- What does preferred stock mean?
- Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.